Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 17/04/20021 min de leitura
Determination of Regulatory Review Period for Purposes of Patent Extension; MIFEPREX; Extension of Comment Period
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is extending to April 26, 2002, the comment period for the regulatory review period determination for MIFEPREX, published in the Federal Register of January 25, 2002 (67 FR 3724). The agency is taking this action in response to a request for an extension.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →